US 12,303,413 B2
Orientable implantable device and method
Daniel Ezra Walzman, Bergenfield, NJ (US)
Filed by Daniel Ezra Walzman, Bergenfield, NJ (US)
Filed on Nov. 1, 2021, as Appl. No. 17/515,756.
Application 17/515,756 is a continuation in part of application No. 17/246,853, filed on May 3, 2021, granted, now 11,723,785.
Application 17/515,756 is a continuation in part of application No. 16/888,813, filed on May 31, 2020, granted, now 11,638,655.
Application 17/246,853 is a continuation of application No. 16/852,488, filed on Apr. 19, 2020, granted, now 11,045,177, issued on Jun. 29, 2021.
Claims priority of provisional application 63/109,387, filed on Nov. 4, 2020.
Claims priority of provisional application 62/921,574, filed on Jun. 25, 2019.
Claims priority of provisional application 62/921,378, filed on Jun. 12, 2019.
Prior Publication US 2022/0054119 A1, Feb. 24, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 2/958 (2013.01); A61B 17/00 (2006.01); A61B 17/12 (2006.01); A61F 2/856 (2013.01); A61F 2/90 (2013.01); A61F 2/95 (2013.01); A61F 2/954 (2013.01); A61F 2/966 (2013.01); A61B 90/00 (2016.01); A61F 2/06 (2013.01); A61F 2/82 (2013.01); A61M 25/00 (2006.01)
CPC A61F 2/958 (2013.01) [A61B 17/00234 (2013.01); A61B 17/12113 (2013.01); A61B 17/12118 (2013.01); A61F 2/856 (2013.01); A61F 2/90 (2013.01); A61F 2/95 (2013.01); A61F 2/9517 (2020.05); A61F 2/954 (2013.01); A61F 2/966 (2013.01); A61B 2017/00292 (2013.01); A61B 17/0057 (2013.01); A61B 2017/1205 (2013.01); A61B 17/12172 (2013.01); A61B 2090/3966 (2016.02); A61F 2002/061 (2013.01); A61F 2002/823 (2013.01); A61F 2002/9534 (2013.01); A61F 2002/9583 (2013.01); A61F 2230/0004 (2013.01); A61F 2230/0017 (2013.01); A61F 2230/0023 (2013.01); A61F 2250/0023 (2013.01); A61F 2250/0024 (2013.01); A61F 2250/0098 (2013.01); A61M 2025/0008 (2013.01); A61M 25/0097 (2013.01)] 13 Claims
OG exemplary drawing
 
1. An intravascular system for treating a blood vessel, the intravascular system comprising:
a first catheter defining a first lumen terminating in a distal end hole, the first lumen having a first non-circular transverse cross-sectional configuration; and
a first delivery device configured for insertion into the first lumen of the first catheter, the first delivery device including:
a first implantable medical device;
a first elongated member supporting the first medical device such that the first elongated member and the first medical device are movable through the first lumen to facilitate delivery of the first medical device to a target location within the blood vessel, the first elongated member having a second non-circular transverse cross-sectional configuration corresponding to the first non-circular transverse cross-sectional configuration to thereby inhibit rotation of the first elongated member within the first catheter and control orientation of the first medical device relative to the first catheter; and
a hub at a proximal end of the first catheter, wherein an inner shape of the hub and an outer shape of a distal end of a delivery catheter are configured in noncircular configurations so that the distal end of the delivery catheter is insertable into the hub to thereby inhibit rotation of the delivery catheter relative to the first catheter, and thereby facilitate transfer of the first elongated member to the first catheter and control orientation of the first medical device relative to the first catheter;
wherein two or more of the hub, first catheter, first elongated member and first medical device have at least one marker, wherein the markers are at a substantially same circumferential rotation.